VitaLink acquires Comprehensive Clinical Trials

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/usanpetkovic)
(Image: Getty/usanpetkovic)

Related tags: Clinical trial site, Women's health, Clinical trials

The clinical research site business, VitaLink Research, has acquired FL-based Comprehensive Clinical Trials, which conducts women’s health-focused Ph II-IV clinical trials.

VitaLink Research (VLR) today announced its acquisition of Comprehensive Clinical Trials (CCT).

Founded in 2004, VLR has 13 locations in the US. According to the company, headquartered in Greenville, SC, the addition expands its reach throughout the Southeast.

“The partnership with Comprehensive Clinical Trials is a critical milestone in the company’s expansion into the growing field of women’s health,”​ said Nick Wright, CEO of VitaLink Research, in a statement.

Dr. Ronald Ackerman, founder of CCT, will continue to lead the CCT business. Said Ackerman, “The strong infrastructure that VitaLink has established will enable CCT to focus exclusively on clinical research and expanding our women’s health expertise throughout the VitaLink network.”

VTL is owned by the health care investment firm, Great Point Partners (GPP), based in Greenwich, CT. The company has approximately $1bn of equity capital under management.

Related news

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us


View more